Prasol Chemicals IPO 2026: ₹500 Crore Issue Opens September 8 — Price, Lot Size, Financials and Key Risks
Prasol Chemicals IPO is set to open for subscription on September 8, 2026, allowing investors to participate in a specialty chemicals company serving a range of industrial applications.
The company plans to raise approximately ₹500 crore through a mainboard IPO comprising a fresh issue of approximately ₹80 crore and an Offer for Sale of up to 62.13 lakh equity shares.
The IPO price band has been fixed at ₹643 to ₹676 per share. The minimum application is for 22 shares, requiring an investment of ₹14,872 at the upper price band.
The shares are proposed to be listed on both the BSE and NSE.
Prasol Chemicals IPO: Key Details
- IPO Open Date: September 8, 2026
- IPO Close Date: September 10, 2026
- Price Band: ₹643–₹676 per share
- Face Value: ₹2 per share
- Issue Size: Approximately ₹500 crore
- Fresh Issue: Approximately ₹80 crore
- Offer for Sale: Up to 62,13,006 shares
- Lot Size: 22 shares
- Minimum Investment: ₹14,872
- Retail Quota: 35%
- NII Quota: 15%
- QIB Quota: 50%
- Listing: BSE and NSE
- Basis of Allotment: September 11, 2026
- Expected Listing Date: September 16, 2026
- Lead Manager: DAM Capital Advisors
- Registrar: KFin Technologies
What Does Prasol Chemicals Do?
Prasol Chemicals operates in the specialty chemicals industry, supplying chemical products for industrial applications.
The company is based in Navi Mumbai, Maharashtra, and its business is linked to the broader specialty and performance chemicals market.
The specialty chemicals sector has gained importance as manufacturers across pharmaceuticals, agriculture, coatings, polymers and other industrial segments increasingly require application-specific chemical products.
For investors, the attractiveness of Prasol Chemicals therefore depends not only on overall chemical-sector growth but also on the company’s ability to maintain margins, expand its product portfolio and manage raw-material costs.
Prasol Chemicals IPO: Why the Chemical Sector Matters
India’s specialty chemicals industry has long-term growth opportunities because of increasing domestic manufacturing, import substitution, and the global diversification of chemical supply chains.
Indian chemical manufacturers can potentially benefit from:
- Growing domestic industrial demand
- Import substitution
- Export opportunities
- China-plus-one strategies
- Expansion of downstream manufacturing
- Increasing demand for specialty and performance chemicals
However, the chemical industry is cyclical in several segments.
Margins can be affected by raw-material prices, international demand, capacity additions, and changes in global chemical prices.
Therefore, investors should evaluate Prasol Chemicals on its individual product portfolio and profitability rather than assuming that the entire chemical sector will grow at the same pace.
How Will Prasol Chemicals Use IPO Funds?
The fresh issue component of approximately ₹80 crore is relatively small compared with the overall IPO size.
According to the IPO details, ₹60 crore will be used for repayment and/or prepayment of certain borrowings.
The remaining proceeds are intended for general corporate purposes.
The debt-repayment component is an important positive because reducing borrowings can help lower interest costs and strengthen the company’s balance sheet.
However, investors should note that a large part of the overall IPO represents an Offer for Sale, meaning those proceeds will go to existing shareholders rather than directly to the company.
Prasol Chemicals Financial Performance
The company has reported strong growth in revenue and profitability over the periods presented in its IPO details.
Its reported financial performance is:
- FY2024 Revenue: ₹887.56 crore
- FY2024 PAT: ₹18.13 crore
- FY2025 Revenue: ₹1,015.54 crore
- FY2025 PAT: ₹43.57 crore
- FY2026 Revenue: ₹1,237.85 crore
- FY2026 PAT: ₹83.12 crore
Revenue increased from ₹887.56 crore in FY2024 to ₹1,237.85 crore in FY2026.
More importantly, profit increased substantially from ₹18.13 crore to ₹83.12 crore over the same period.
This combination of revenue growth and significant improvement in profitability is one of the key factors supporting the IPO investment case.
Strong Improvement in Profitability
The company reports FY2026:
- ROE: 20.37%
- ROCE: 22.43%
- EBITDA Margin: 11.30%
- PAT Margin: 6.74%
- Basic EPS: ₹14.33
- NAV: ₹77.33
- Debt-to-Equity: 0.19
The relatively low reported debt-to-equity ratio is a positive factor.
The improvement in profitability is also notable, although investors should examine whether the company’s margins can remain stable as chemical-market conditions change.
Prasol Chemicals IPO Valuation
At the upper price band of ₹676, investors are paying a significant premium to the company’s reported FY2026 NAV of ₹77.33 per share.
Based on the reported FY2026 basic EPS of ₹14.33, the implied P/E is approximately 47 times.
This makes valuation an important consideration for investors.
The company’s recent earnings growth is strong, but the IPO price already appears to factor in a substantial amount of future growth.
Therefore, investors should ask whether Prasol Chemicals can sustain its earnings momentum after listing.
Comparison With Chemical Industry Peers
The IPO information provides a comparison with several listed chemical companies, including:
- Aarti Industries
- Atul
- Laxmi Organics Industries
- Vinati Organics
- Privi Speciality Chemicals
- Yasho Industries
- Excel Industries
The peer valuations vary considerably.
For example, the reported P/E multiples range from around 17 times for Excel Industries to more than 200 times for Yasho Industries, highlighting the wide valuation differences across the chemical sector.
Prasol Chemicals therefore needs to be assessed not simply against the average sector multiple, but against companies with comparable products, margins, growth rates and business profiles.
Promoter Holding
The promoters and promoter group currently hold approximately 89.20% of the company.
Following the IPO, their holding is expected to decline to approximately 76.92%.
This means promoters will continue to retain a substantial majority stake after listing.
High promoter ownership can provide strong alignment with shareholders, although investors should also examine the company’s related-party transactions, governance record and post-IPO shareholding structure.
Key Positives of Prasol Chemicals IPO
Strong Revenue Growth
Revenue increased from ₹887.56 crore in FY2024 to ₹1,237.85 crore in FY2026.
Significant Profit Growth
Profit increased from ₹18.13 crore to ₹83.12 crore during the same period.
Low Debt Relative to Equity
The reported debt-to-equity ratio of 0.19 indicates relatively moderate leverage.
Debt Reduction Through IPO
₹60 crore of the fresh issue is proposed to be used for repayment or prepayment of borrowings.
Exposure to Specialty Chemicals
The company operates in an industry that could benefit from India’s growing manufacturing base and increasing demand for specialty chemical products.
Key Risks Investors Should Watch
Valuation
At the upper price band, the IPO works out to approximately 47 times FY2026 earnings based on the reported EPS of ₹14.33.
This leaves relatively limited room for earnings disappointment.
Chemical Industry Cyclicality
Chemical companies can experience significant fluctuations in demand and margins depending on global commodity cycles.
Raw-Material Costs
Changes in the prices and availability of raw materials can affect operating margins.
Large OFS Component
A substantial portion of the IPO is an Offer for Sale. Investors should understand that these proceeds do not directly strengthen the company’s balance sheet.
Execution and Growth Risk
The valuation assumes continued earnings growth. Any slowdown in revenue or profit growth could affect the stock’s valuation after listing.
Prasol Chemicals IPO GMP
The Grey Market Premium (GMP) can provide an indication of unofficial market sentiment before listing, but it should not be considered a guaranteed listing gain.
GMP can change quickly based on subscription levels, market conditions, and investor sentiment.
For Prasol Chemicals, investors should focus more on earnings growth, margins, debt, valuation, and long-term demand for its products than on short-term grey-market movements.
Prasol Chemicals IPO Important Dates
The IPO will open on September 8, 2026, and close on September 10, 2026.
The expected schedule is:
IPO Opens: September 8, 2026
IPO Closes: September 10, 2026
Basis of Allotment: September 11, 2026
Refunds: September 15, 2026
Shares Credited: September 15, 2026
Listing: September 16, 2026
Prasol Chemicals IPO: Investor View
Prasol Chemicals enters the IPO market with a combination of strong recent revenue growth, significant improvement in profitability, and relatively moderate leverage.
Revenue crossed ₹1,200 crore in FY2026, while profit increased to more than ₹83 crore.
The proposed use of ₹60 crore for debt repayment is another positive because it could help improve the balance sheet.
However, the biggest concern is valuation.
At the upper price band of ₹676, the IPO is valued at approximately 47 times FY2026 earnings based on reported EPS. Investors are therefore paying for continued growth rather than simply buying the company’s current earnings.
The specialty chemicals opportunity is attractive, but investors should also consider raw-material volatility, global chemical cycles, and the possibility of margin pressure.
Conclusion
The Prasol Chemicals IPO is a ₹500 crore mainboard issue with a price band of ₹643 to ₹676 per share.
The company has demonstrated strong financial growth, with revenue increasing to ₹1,237.85 crore and profit reaching ₹83.12 crore in FY2026.
Its relatively low leverage and planned repayment of ₹60 crore of borrowings are additional positives.
However, investors should carefully assess the IPO valuation, earnings sustainability and chemical-sector cyclicality before subscribing.
The IPO could appeal to investors looking for exposure to India’s specialty chemicals industry, but the valuation means that future earnings growth will be critical to the investment case.
Investors should read the company’s RHP and evaluate the risk factors before making an IPO investment decision.